Oncology

n a new 5-year follow-up study exploring diagnostic tools for adenocarcinoma of the esophagogastric junction (AEG), PET combined with MRI (PET/MRI) has shown strong potential for predicting long-term survival.

Cancer survivors face a significantly increased risk of cardiovascular mortality, according to a major nationwide study in Japan that highlights key differences in cardiovascular risk across cancer types and specific heart-related diseases.

At the 2025 AACR Annual Meeting, researchers unveiled an AI-driven model that significantly improves the early detection of cancer cachexia by analyzing routinely collected diagnostic imaging and clinical data.

Cancer-related fatigue and depression in survivors are strongly associated with a drop in recreational physical activities and overall quality of life, according to data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025.

AI-based models analyzing digital pathology images may offer a major leap in pediatric sarcoma diagnosis accuracy, according to research presented at the American Association for Cancer Research Annual Meeting 2025.

Breast cancer mortality in women aged 20 to 49 has significantly declined across all racial and molecular subgroups, according to findings presented at the AACR Annual Meeting 2025 in Chicago, Illinois.

Patients with newly diagnosed, locally advanced head and neck squamous cell carcinoma (HNSCC) may soon benefit from a major shift in treatment strategy, as phase III trial data show that perioperative pembrolizumab significantly improves outcomes when added to standard care.

Promising new data emerged on zongertinib, an investigational oral therapy targeting HER2 mutations in advanced non-small cell lung cancer (NSCLC), was presented at the AACR Annual Meeting 2025 in Chicago.